Ibex Breast HER2 assists pathologists with accurate & reproducible HER2 scoring, including the highly subjective HER2-low cases. As a fully automated "zero-click" AI solution, it detects invasive tumor cell staining patterns & delineates HER2 expression into four standard scores: 0, 1+, 2+ and 3+, based on the 2023 ASCO/CAP guidelines. Benefits:
• “Zero-click” invasive tumor detection (automatically excluding DCIS)
• Automated tumor cell identification & staining pattern classification
• Scoring explainability with visualization of AI findings & staining pattern percentages
The AI is exceptionally robust, with high performance across multiple labs, scanners and patient demographics. Ibex Breast HER2 is part of Ibex Breast, an integrated AI solution offering a streamlined diagnostic workflow.
Application can be launched from Sectra's pathology image window: Yes
Results will be shown in Sectra's pathology image window: No
Ask your Sectra representative which version of the Sectra PACS is compatible with the highlighted integration standards.
Contact usAre you interested in learning more? Please do not hesitate to get in touch with us at Sectra.
The application content is provided by the respective AI vendors.
